FINWIRES · TerminalLIVE
FINWIRES

Tesla Capital Spending Boost to Eventually Bring in More Revenue, UBS Says

-- Tesla's (TSLA) aggressive capital spending on artificial intelligence initiatives should boost revenue, though it may take some time before those gains materialize, UBS Securities said in a Thursday note to clients.

The electric vehicle manufacturer now sees more than $25 billion in capital investment, Chief Financial Officer Vaibhav Taneja said during an earnings call late Wednesday. In January, he said 2026 capex would be "in excess of $20 billion."

At the same time, Taneja flagged a negative free cash flow for the rest of 2026 on Wednesday. The company is paying for six factories and has enhanced its investment in AI-related initiatives, including the infrastructure to support Robotaxi and the launch of autonomous humanoid robot Optimus, he told analysts.

"We are in a very big capital investment phase, which is going to start now and would last a couple of years," Taneja said.

Tesla shares were down 2.4% intraday Thursday, despite the company reporting stronger-than-expected first-quarter results.

"We expect elevated capex for a number of years," UBS analysts including Joseph Spak wrote. "(Tesla's) physical AI ventures offer large potential revenue opportunities, but (it) could take a while to get there."

Tesla reported first-quarter capex of $2.49 billion, indicating a "big step up" for the rest of the year, Spak said.

"Since we expect capex to remain elevated over coming years, we see potential for depreciation to more than double over coming years weighing on (earnings per share)," Spak said.

UBS reiterated its neutral rating on Tesla's shares, while raising its price target to $364 from $352.

The brokerage upgraded its EPS projections for Tesla to $2 from $1.83 for 2026 and to $2.43 from $2.35 for 2027.

"Overall, we continue to believe current levels more properly balance the long-term opportunity with near-term concerns on fundamentals and potential fund flows," Spak said.

On the call, Tesla Chief Executive Elon Musk said the company's increased capital investments are "well justified."

"I think you've seen in most, if not all, certainly the major technology companies, substantially increasing their capital investments, and we're going to be doing the same," he told analysts. "I think it's going to pay off in a very big way. So we're investing in and improving our core technologies, battery, powertrain, AI software, AI training, chip design, manufacturing, laying the groundwork for significantly increased manufacturing production."

Price: $378.27, Change: $-9.24, Percent Change: -2.38%

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB